Amisulpride is indicated for:
Population group: both men and women, only adults (18 - 65 years old)
Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Amisulpride is contraindicated in the following cases: